Figure 4.
Representative survival curves for 4(1H)-quinolones 12 (A), 62 (B), and 67 (C) that demonstrate enhanced in vivo efficacy congruent with sequential improved physiological properties of the series.
Representative survival curves for 4(1H)-quinolones 12 (A), 62 (B), and 67 (C) that demonstrate enhanced in vivo efficacy congruent with sequential improved physiological properties of the series.